• Pharma
  • June 30, 2020
  • 39 views
Bharat Biotech’s COVAXIN gets DCGI approval for Phase I & II Human Clinical Trials

COVAXIN has been successfully developed by Bharat Biotech, a vaccine for COVID-19 by collaborating with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV). The SARS-CoV-2…